STOCK TITAN

Tactile Systems SEC Filings

TCMD NASDAQ

Welcome to our dedicated page for Tactile Systems SEC filings (Ticker: TCMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Reimbursement shifts, FDA clearances, and clinical trial outcomes make Tactile Systems Technology’s disclosures challenging to navigate. If you have ever searched for “Tactile Systems Technology SEC filings explained simply”, you know the struggle of pulling vital details about Flexitouch adoption or payer mix from hundreds of pages.

Stock Titan solves that problem. Our AI parses every Tactile Systems Technology annual report 10-K simplified, flags reimbursement-risk language, and highlights segment revenue so you can focus on decisions, not document hunting. Need the newest Tactile Systems Technology quarterly earnings report 10-Q filing? It appears here the moment EDGAR posts, complete with an Tactile Systems Technology earnings report filing analysis that translates GAAP footnotes into plain English. Material announcements? See Tactile Systems Technology 8-K material events explained in seconds—including any FDA clearances or coding updates.

  • Track Tactile Systems Technology insider trading Form 4 transactions or set alerts for Tactile Systems Technology Form 4 insider transactions real-time.
  • Review the Tactile Systems Technology proxy statement executive compensation section to see how management incentives align with clinical milestones.
  • Drill into understanding Tactile Systems Technology SEC documents with AI—from revenue by payer class to patent litigation disclosures.

Whether you are monitoring Tactile Systems Technology executive stock transactions Form 4 before a product update or comparing compression-therapy unit sales across periods, Stock Titan’s real-time feed and expert notes keep you ahead. No more paging through dense exhibits—our AI-powered summaries convert complex medical-device filings into actionable insight, updated the moment TCMD submits a document.

Rhea-AI Summary

On 08/08/2025 Sheri Louise Dodd, a director and the Chief Executive Officer of Tactile Systems Technology, sold 7,762 shares of the company’s common stock at $12.356 per share. The Form 4 states the shares were sold to cover taxes associated with the settlement of restricted stock units.

Following the reported sale, Ms. Dodd beneficially owns 173,479 shares, held directly. The disclosure is a routine RSU tax-withholding sale and the form does not report any additional purchases, option exercises, or other material changes to her ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Tactile Systems Technology, Inc. (TCMD) submitted a Form 144 reporting a proposed sale of 7,762 common shares with an aggregate market value of $95,905.72. The filing names Fidelity Brokerage Services LLC as the broker and lists 22,292,145 shares outstanding. The approximate sale date is 08/08/2025 and the securities are listed on NASDAQ. The reported acquisition occurred on 08/07/2025 and is described as Restricted Stock Vesting, with payment characterized as Compensation. The form indicates Nothing to Report for securities sold in the past three months and was submitted as a LIVE filing. The signature section includes the required representation about lack of undisclosed material information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Cadian Capital Management, LP, its general partner Cadian Capital Management GP, LLC, and managing member Eric Bannasch filed Amendment No. 2 to Schedule 13G on Tactile Systems Technology, Inc. (NASDAQ: TCMD).

  • Current position: 2,192,823 common shares as of 7 Aug 2025, representing 9.8 % of outstanding stock (22,292,145 shares outstanding).
  • Prior position: 2,309,616 shares (10.4 %) as of 30 Jun 2025. The filing therefore discloses a net reduction of 116,793 shares and a drop below the 10 % reporting threshold.
  • All shares are held by Cadian Master Fund L.P. and Cadian Opportunities Master Fund LP. The adviser exercises shared voting and dispositive power; no sole power is reported.
  • The securities are held in the ordinary course; the group affirms no intent to influence control of the issuer.

The amendment signals that a major institutional holder remains the company’s largest known shareholder but has modestly trimmed its passive stake.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.79%
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
26.79%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Tactile Systems (TCMD)?

The current stock price of Tactile Systems (TCMD) is $13.7 as of September 17, 2025.

What is the market cap of Tactile Systems (TCMD)?

The market cap of Tactile Systems (TCMD) is approximately 307.6M.
Tactile Systems

NASDAQ:TCMD

TCMD Rankings

TCMD Stock Data

307.63M
21.69M
2.74%
100.59%
9.54%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MINNEAPOLIS